NEW YORK, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Designer Brands Inc. ("Designer Brands" or the "Company") (NYSE:DBI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Designer Brands and certain of its officers […]
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of KBR, Inc. ("KBR" or the "Company") (NYSE:KBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether KBR and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. ("Edgewise" or the "Company") (NASDAQ:EWTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Edgewise and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Unicycive Therapeutics, Inc. ("Unicycive" or the "Company") (NASDAQ:UNCY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Unicycive and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ:PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether PetMed and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Funko, Inc. ("Funko" or the "Company") (NASDAQ:FNKO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Funko and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of WPP plc ("WPP" or the "Company") (NASDAQ:WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether WPP and certain of its officers and/or directors have
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. ("Simulations Plus" or the "Company") (NASDAQ:SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Simulations Plus and certain of its
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of The J.M. Smucker Company ("Smucker" or the "Company") (NYSE:SJM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Smucker and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of GSK plc ("GSK" or the "Company") (NYSE:GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GSK and certain of its officers and/or directors